Track topics on Twitter Track topics that are important to you
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS.
CALGARY, Alberta, Sept. 24, 2018 (GLOBE NEWSWIRE) -- RMMI Corp. (“RMMI” or the “Company”) is pleased to announce today that it has successfully completed its initial public offering (the “Offering”) of 1,765,700 common shares of RMMI at a price of $2.50 per common share for gross proceeds of approximately $4.4 million. Subject to RMMI fulfilling certain customary Canadian Securities Exchange (“CSE”) requirements, the common shares of RMMI are expected to commence trading on the CSE on September 25, 2018 under the trading symbol “RMMI”.
“Management and the Board of Directors are extremely pleased with the successful completion of our initial public offering and we look forward to having RMMI trading on the CSE,” said Earl Connors, President and CEO of RMMI. “We are proud to announce that RMMI has joined the growing family of cannabis companies listed on the CSE and believe this represents an important milestone for the Company and its shareholders. RMMI was able to complete this milestone within two years of incorporation, which speaks to the dedication and hard work of our team. We will continue to build on this foundation, enhancing shareholder value, increasing liquidity and executing our strategy.”
The Offering was made on a commercially reasonable efforts basis and was led by Canaccord Genuity Corp., as lead agent, and Haywood Securities Inc. as co-agent (collectively, the “Agents”). In connection with the Offering, the Agents received a cash commission and were granted compensation warrants. RMMI has granted the Agents an over-allotment option (the “Over-Allotment Option”) that is exercisable at the Agents’ sole discretion, to offer for purchase and sale additional common shares of RMMI in an amount that is equal to 15% of the total number of common shares issued under the Offering at a price of $2.50 per common share. The Agents may exercise the Over-Allotment Option, in whole or in part, at any time on or before the date that is 60 days following the date of closing of the Offering.
An amended and restated (final) prospectus relating to the Offering has been filed with securities commissions in the provinces of Alberta, British Columbia and Ontario, and a copy is available under RMMI’s profile on SEDAR at www.sedar.com.
No securities regulatory authority has either approved or disapproved of the contents of this news release. The common shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws. Accordingly, the common shares may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of RMMI in any jurisdiction in which such offer, solicitation or sale would be unlawful.
About RMMI Corp.
RMMI is an Alberta-based company focused on the production, cultivation and sale of medical marijuana in various forms. RMMI, through its wholly-owned subsidiary, Rocky Mountain Marijuana Inc. (“Rocky Mountain”) is a late stage applicant under the Access to Cannabis for Medical Purposes Regulations (Canada) and is in the process of obtaining the requisite license to commence cannabis production operations. Rocky Mountain blends science with nature using aeroponic cultivation and CO2 extraction. Rocky Mountain intends to produce high-purity, organic-quality cannabis oils. RMMI’s team will employ leading commercially available science and technology to maximize production yields and product quality as a low-cost producer, while reducing risk to its crops and its business.
For more information about RMMI, please visit www.rmmi.ca.
Forward Looking Statements
Certain statements contained in this news release constitute “forward-looking statements” or “forward-looking information” within the meaning of the applicable securities legislation (collectively, “forward-looking statements”). These statements relate to management’s expectations about future events, results of operations and RMMI’s future performance (both operational and financial) and business prospects. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “contemplate,” “continue,” “propose,” “predict,” “plan,” “goal,” “seek,” “believe,” “project,” “forecast,” “pursue,” “potential,” “objective,” “estimate,” “expect,” “strategy,” “future,” “likely,” “might,” “may,” “shall,” “should,” “could,” “will,” “capable,” and similar references to future periods. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. Unless otherwise indicated, these statements speak only as of the date of this news release. In particular, this news release contains forward-looking statements pertaining to the following: the exercise of the Over-Allotment Option by the Agents (if any) and the commencement of trading of the Company’s common shares on the CSE.
Forward-looking statements are based on certain assumptions and analyses made by RMMI in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate and are subject to risks and uncertainties. In making the forward-looking statements included in this news release, RMMI has made the following assumptions: that market conditions and regulatory requirements will not change in any material respect such that the Company’s common shares will successfully commence trading on the CSE; general business and economic conditions and RMMI's ability to successfully execute its plans and intentions. Although RMMI believes that these assumption are reasonable, they may prove to be incorrect, and RMMI cannot assure that actual results will be consistent with the forward-looking statements included in this news release. Given these risks, uncertainties and assumptions, prospective purchasers of common shares should not place undue reliance on the forward-looking statements in this news release. In fact, RMMI’s actual results could differ materially from those anticipated in the forward-looking statements as a result of the risk factors and other factors set forth in its amended and restated prospectus dated June 26, 2018.
The forward-looking statements included in this news release are expressly qualified by this cautionary statement and, except as otherwise indicated, are made as of the date of this news release. RMMI does not undertake any obligation to publicly update or revise any forward-looking statements or departures from them except as required by applicable securities laws. All of the forward-looking statements contained in this news release are expressly qualified by the foregoing cautionary statements.
Earl Connors, President and Chief Executive Officer
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...